Portal de Periódicos da CAPES

Increasing Costs of Urinary Incontinence Among Female Medicare Beneficiaries

2006; Lippincott Williams & Wilkins; Volume: 176; Issue: 1 Linguagem: Inglês

10.1016/s0022-5347(06)00588-x

1527-3792

Jennifer T. Anger, Christopher S. Saigal, Rodger Madison, Geoffrey Joyce, Mark S. Litwin,

Diverticular Disease and Complications

No AccessJournal of UrologyAdult urology1 Jul 2006Increasing Costs of Urinary Incontinence Among Female Medicare Beneficiaries Jennifer T. Anger, Christopher S. Saigal, Rodger Madison, Geoffrey Joyce, Mark S. Litwin, and Urologic Diseases of America Project Jennifer T. AngerJennifer T. Anger , Christopher S. SaigalChristopher S. Saigal , Rodger MadisonRodger Madison , Geoffrey JoyceGeoffrey Joyce , Mark S. LitwinMark S. Litwin , and Urologic Diseases of America Project View All Author Informationhttps://doi.org/10.1016/S0022-5347(06)00588-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We measured the financial burden of urinary incontinence in the United States from 1992 to 1998 among women 65 years old or older. Materials and Methods: We analyzed Medicare claims for 1992, 1995 and 1998 and estimated spending on the treatment of urinary incontinence. Total costs were stratified by type of service (inpatient, outpatient and emergency department). Results: Costs of urinary incontinence among older women nearly doubled between 1992 and 1998 in nominal dollars, from $128 million to $234 million, primarily due to increases in physician office visits and ambulatory surgery. The cost of inpatient services increased only slightly during the period. The increase in total spending was due almost exclusively to the increase in the number of women treated for incontinence. After adjusting for inflation, per capita treatment costs decreased about 15% during the study. Conclusions: This shift from inpatient to outpatient care likely reflects the general shift of surgical procedures to the outpatient setting, as well as the advent of new minimally invasive incontinence procedures. In addition, increased awareness of incontinence and the marketing of new drugs for its treatment, specifically anticholinergic medication for overactive bladder symptoms, may have increased the number of office visits. While claims based Medicare expenditures are substantial, they do not include the costs of pads or medications and, therefore, underestimate the true financial burden of incontinence on the aging community. References 1 : Urinary incontinence in women. In: Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Edited by . Washington, D. C: US Government Publishing Office2004: 71. NIH Publication No. 04-5512, Also accessible at www.uda.niddk.nih.gov.. Google Scholar 2 : Urologic Diseases in America Project: urinary incontinence in women—national trends in hospitalizations, office visits, treatment and economic impact. J Urol2005; 173: 1295. Link, Google Scholar 3 : Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol2003; 188: S77. Google Scholar 4 : Annual direct cost of urinary incontinence. Obstet Gynecol2001; 98: 398. Google Scholar 5 : Methods. In: Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Edited by . Washington, D. C: US Government Publishing Office2004: 283. NIH Publication No. 04-5512. Also accessible at www.uda.niddk.nih.gov.. Google Scholar 6 : Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care2002; 40: 104. Google Scholar 7 : The rising prevalence of treated disease: effects on private health insurance spending. Health Aff (Millwood). : 2005. Jan-Jun, suppl., web exclusives: W5-317-W5-325. Google Scholar 8 : National public health policies for prevention and care in urinary incontinence in the elderly. World J Urol1998; 16: S71. Google Scholar 9 : Cost-Effectiveness in Health and Medicine. New York: Oxford University Press1996: xxiii. 425. Google Scholar 10 : Incontinence, 2nd International Consultation on Incontinence. London: Plymbridge Distribution Ltd2002. Paris. July 1–3, 2001. Google Scholar 11 : Estimated costs of treating stress urinary incontinence in elderly women according to the AHCPR clinical practice guidelines. Am J Manag Care1996; 2: 147. Google Scholar 12 : Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol2003; 21: 401. Google Scholar Departments of Urology and Health Services, University of California, Los Angeles, David Geffen School of Medicine and School of Public Health, Los Angeles, and Rand Corporation, Santa Monica, California© 2006 by American Urological AssociationFiguresReferencesRelatedDetailsCited ByGriebling T (2018) Re: Urinary Incontinence, Functional Status, and Health-Related Quality of Life among Medicare Beneficiaries Enrolled in the Program for All-Inclusive Care for the Elderly and Dual Eligible Demonstration Special Needs PlansJournal of Urology, VOL. 191, NO. 2, (420-422), Online publication date: 1-Feb-2014. Volume 176Issue 1July 2006Page: 247-251 Advertisement Copyright & Permissions© 2006 by American Urological AssociationKeywordswomen's healthurinary incontinenceMedicareeconomicscosts and cost analysisMetricsAuthor Information Jennifer T. Anger More articles by this author Christopher S. Saigal More articles by this author Rodger Madison More articles by this author Geoffrey Joyce More articles by this author Mark S. Litwin Financial interest and/or other relationship with Sanofi-Synthelabo, Amgen and TAP Pharmaceuticals. More articles by this author Urologic Diseases of America Project More articles by this author Expand All Advertisement PDF DownloadLoading ...